AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Nykode Therapeutics AS

NOK 3.00 +$0.65 (+27.33%)
OSL · 30 Oct 2026 15:25 UTC
Previous Close
NOK 3.02
Day Range
NOK 2.94NOK 3.08
Year Range
NOK 2.06NOK 5.20
Market Cap
1.18B
AVG Volume
1.68M
Trailing/Forward PE
-4.69/65.54
PEG ratio
-0.05
Dividend Yield
-
Next Earnings Date
2026-11-25
Primary Exchange
Oslo Stock ExchangeNO
Revenue (USD) · TTM
020M40M60M80M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NYKD.OL Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q2106K
26 Q1198K
25 Q4335K
25 Q37.11M
25 Q27.64M
25 Q17.99M
24 Q48.68M
24 Q33.92M
24 Q26.15M
24 Q160.34M
Net Income (USD) · TTM
-150M-100M-50M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NYKD.OL Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q2-22.95M
26 Q1-14.9M
25 Q4-12.25M
25 Q3-11M
25 Q2-17.07M
25 Q1-25.32M
24 Q4-38.82M
24 Q3-37.4M
24 Q2-37.91M
24 Q1-129.39M
Operating Income (USD) · TTM
-200M-150M-100M-50M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NYKD.OL Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q2-28.03M
26 Q1-27.76M
25 Q4-28.59M
25 Q3-26.49M
25 Q2-35.16M
25 Q1-40.27M
24 Q4-48.33M
24 Q3-59.49M
24 Q2-58.85M
24 Q1-175.21M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: NYKD.OL

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 25 Nov 2026.

Nykode Therapeutics AS
NYKD.OL
Stockpicker

Video analysis: NYKD.OL

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: NYKD.OL

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.